DKDCA vs. AIKI, ISPC, FOXO, FNVT, MNTN, AFAC, THAC, AVAC, IQV, and ICLR
Should you be buying Data Knights Acquisition stock or one of its competitors? The main competitors of Data Knights Acquisition include AIkido Pharma (AIKI), iSpecimen (ISPC), FOXO Technologies (FOXO), Finnovate Acquisition (FNVT), Everest Consolidator Acquisition (MNTN), Arena Fortify Acquisition (AFAC), Thrive Acquisition (THAC), Avalon Acquisition (AVAC), IQVIA (IQV), and ICON Public (ICLR).
AIkido Pharma (NASDAQ:AIKI) and Data Knights Acquisition (NASDAQ:DKDCA) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, community ranking, media sentiment, analyst recommendations, risk, dividends and valuation.
10.9% of AIkido Pharma shares are owned by institutional investors. Comparatively, 35.3% of Data Knights Acquisition shares are owned by institutional investors. 8.6% of AIkido Pharma shares are owned by insiders. Comparatively, 45.7% of Data Knights Acquisition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
AIkido Pharma received 101 more outperform votes than Data Knights Acquisition when rated by MarketBeat users.
AIkido Pharma's return on equity of 0.00% beat Data Knights Acquisition's return on equity.
Data Knights Acquisition has lower revenue, but higher earnings than AIkido Pharma. Data Knights Acquisition is trading at a lower price-to-earnings ratio than AIkido Pharma, indicating that it is currently the more affordable of the two stocks.
AIkido Pharma has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500. Comparatively, Data Knights Acquisition has a beta of 0.18, indicating that its stock price is 82% less volatile than the S&P 500.
In the previous week, Data Knights Acquisition's average media sentiment score of 0.00 equaled AIkido Pharma'saverage media sentiment score.
Summary
Data Knights Acquisition beats AIkido Pharma on 6 of the 10 factors compared between the two stocks.
Get Data Knights Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for DKDCA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DKDCA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
DKDCA vs. The Competition
Data Knights Acquisition Competitors List
Related Companies and Tools
